A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Working-age Americans who get health insurance through their job will see largest health insurance rate hikes since 2010.

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

Eli Lilly (LLY) stock in focus as a federal appeals court upholds a lower court ruling which ordered the company to pay ...

Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company recently completed a ...

Big Pharma faces tariff risks, patent cliffs, and regulatory pressure, but innovation and strong pipelines keep Eli Lilly, ...

Office cluster with Takeda HQ refinances for $1.3B Lilly’s latest $1B+ obesity deal is with Boston biotech Lilly’s latest ...

Takeda names Rhonda Pacheco as U.S. Business Unit President, bringing expertise from Eli Lilly. Read more here.

Novo Nordisk A/S’s new chief executive officer is calling workers back to the office as the Ozempic maker struggles to catch ...

A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh Circuit ruled Thursday.